Michael Yi Ph.D Overview
- Firm
- Hillhouse Invest...
- Primary Position
-
Founding Partner...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Michael Yi Ph.D General Information
Biography
Dr. Michael Yi is the Founding Partner and serves as Co-Chief Investment Officer at Hillhouse Investment Group. He also serves as a Board Member at NextCure. He served as a Board Member at Elpiscience Biopharmaceuticals and HiberCell. He graduated from the Marshall School of Business at the University of Southern California with an M.B.A. and he also holds a B.S. in Engineering from Shanghai Maritime University.
Contact Information
Address
- Beijing
- China
Michael Yi Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Hillhouse Investment Group | Investor | Founding Partner & Co-Chief Investment Officer | Hong Kong, Hong Kong | PE/Buyout |
Michael Yi Ph.D Board Seats (1)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| NextCure | Biotechnology | Publicly Held | Formerly VC-backed | Beltsville, MD |
Michael Yi Ph.D Lead Partner on Deals (11)
Michael Yi Ph.D has been the lead partner on 11 deals. Their latest deal was with Elpiscience Biopharmaceuticals, a pharmaceuticals company. The deal was made for on 13-May-2021.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Elpiscience Biopharmaceuticals | 13-May-2021 | Later Stage VC (Series C) | Completed | Pharmaceuticals | Shanghai, China | |
| AbogenBio | 27-Oct-2020 | Completed | Drug Discovery | Suzhou, China | ||
| I-Mab Biopharma | 04-Sep-2020 | Completed | Drug Discovery | Shanghai, China | ||
| Elpiscience Biopharmaceuticals | 28-Dec-2019 | Completed | Pharmaceuticals | Shanghai, China | ||
| HiberCell | 07-Feb-2019 | Completed | Drug Discovery | New York, NY | ||
| NextCure | 13-Nov-2018 | Completed | Biotechnology | Beltsville, MD | ||
| Elpiscience Biopharmaceuticals | 28-Sep-2018 | Completed | Pharmaceuticals | Shanghai, China | ||
| Viela Bio | 13-Mar-2018 | Completed | Drug Discovery | Gaithersburg, MD | ||
| BeiGene | 13-May-2015 | PE Growth/Expansion | Completed | Drug Discovery | Beijing, China | |
| Huimei Technology | 15-Jan-2015 | Joint Venture | Completed | Outcome Management (Healthcare) | Beijing, China |
Michael Yi Ph.D Network (122)
Board Members (29)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Anne Borgman MD | NextCure | Self | Beltsville, MD | |
| Hongbo Lu Ph.D | Elpiscience Biopharmaceuticals | Lilly Asia Ventures | Shanghai, China | |
| NextCure | Self | Beltsville, MD | ||
| NextCure | Sofinnova Investments | Beltsville, MD | ||
| HiberCell | Self | New York, NY |
Portfolio Executives (89)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Hongtao Lu Ph.D | Elpiscience Biopharmaceuticals | Co-Founder & Chief Scientific Officer & Executive Director | 13-May-2021 | Shanghai, China |
| Xuke Chin MD | Elpiscience Biopharmaceuticals | Chief Medical Officer | 13-May-2021 | Shanghai, China |
| Elpiscience Biopharmaceuticals | Board Member & Director | 13-May-2021 | Shanghai, China | |
| Elpiscience Biopharmaceuticals | Co-Founder, Chief Executive Officer & Chairman | 13-May-2021 | Shanghai, China | |
| Elpiscience Biopharmaceuticals | Chief Financial Officer | 13-May-2021 | Shanghai, China |
Fund Team Members (4)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Lei Zhang | Hillhouse Investment Group | Zhuhai Hillhouse Xinyuan Venture Fund | Hong Kong, Hong Kong |
| Nuoqing Yi | Hillhouse Investment Group | GL Ventures | Hong Kong, Hong Kong |
| Hillhouse Investment Group | Hong Kong, Hong Kong | ||
| Hillhouse Investment Group | Hong Kong, Hong Kong |
Michael Yi Ph.D Affiliated Funds (2)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| GL Ventures | Hillhouse Investment Group | Venture Capital - Early Stage | Closed | 2020 | ||||
| Zhuhai Hillhouse Xinyuan Venture Fund | Hillhouse Investment Group | Venture - General | Closed | 2017 |
Michael Yi Ph.D FAQs
-
Who is Michael Yi Ph.D?
Dr. Michael Yi is the Founding Partner and serves as Co-Chief Investment Officer at Hillhouse Investment Group.
-
How much does Michael Yi Ph.D typically invest?
Michael Yi Ph.D's median deal size is .
-
What is Michael Yi Ph.D’s main position?
Michael Yi Ph.D’s primary position is Founding Partner & Co-Chief Investment Officer.
-
How many active board seats does Michael Yi Ph.D hold?
Michael Yi Ph.D holds a board seat in NextCure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
